180 related articles for article (PubMed ID: 19951947)
1. Determinants for the rhesus monkey TRIM5alpha-mediated block of the late phase of HIV-1 replication.
Sakuma R; Ohmine S; Ikeda Y
J Biol Chem; 2010 Feb; 285(6):3784-3793. PubMed ID: 19951947
[TBL] [Abstract][Full Text] [Related]
2. The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production.
Ohmine S; Sakuma R; Sakuma T; Thatava T; Takeuchi H; Ikeda Y
PLoS One; 2011 Jan; 6(1):e16121. PubMed ID: 21264255
[TBL] [Abstract][Full Text] [Related]
3. Rhesus monkey TRIM5alpha restricts HIV-1 production through rapid degradation of viral Gag polyproteins.
Sakuma R; Noser JA; Ohmine S; Ikeda Y
Nat Med; 2007 May; 13(5):631-5. PubMed ID: 17435772
[TBL] [Abstract][Full Text] [Related]
4. The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha.
Javanbakht H; Diaz-Griffero F; Stremlau M; Si Z; Sodroski J
J Biol Chem; 2005 Jul; 280(29):26933-40. PubMed ID: 15897199
[TBL] [Abstract][Full Text] [Related]
5. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
Stremlau M; Perron M; Welikala S; Sodroski J
J Virol; 2005 Mar; 79(5):3139-45. PubMed ID: 15709033
[TBL] [Abstract][Full Text] [Related]
6. Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains.
Li X; Li Y; Stremlau M; Yuan W; Song B; Perron M; Sodroski J
J Virol; 2006 Jul; 80(13):6198-206. PubMed ID: 16775307
[TBL] [Abstract][Full Text] [Related]
7. Binding of the rhesus TRIM5α PRYSPRY domain to capsid is necessary but not sufficient for HIV-1 restriction.
Yang Y; Brandariz-Nuñez A; Fricke T; Ivanov DN; Sarnak Z; Diaz-Griffero F
Virology; 2014 Jan; 448():217-28. PubMed ID: 24314652
[TBL] [Abstract][Full Text] [Related]
8. A putative SUMO interacting motif in the B30.2/SPRY domain of rhesus macaque TRIM5α important for NF-κB/AP-1 signaling and HIV-1 restriction.
Nepveu-Traversy MÉ; Demogines A; Fricke T; Plourde MB; Riopel K; Veillette M; Diaz-Griffero F; Sawyer SL; Berthoux L
Heliyon; 2016 Jan; 2(1):e00056. PubMed ID: 27441239
[TBL] [Abstract][Full Text] [Related]
9. A B-box 2 surface patch important for TRIM5alpha self-association, capsid binding avidity, and retrovirus restriction.
Diaz-Griffero F; Qin XR; Hayashi F; Kigawa T; Finzi A; Sarnak Z; Lienlaf M; Yokoyama S; Sodroski J
J Virol; 2009 Oct; 83(20):10737-51. PubMed ID: 19656869
[TBL] [Abstract][Full Text] [Related]
10. Restriction of HIV-1 by rhesus TRIM5α is governed by alpha helices in the Linker2 region.
Sastri J; Johnsen L; Smolin N; Imam S; Mukherjee S; Lukic Z; Brandariz-Nuñez A; Robia SL; Diaz-Griffero F; Wiethoff C; Campbell EM
J Virol; 2014 Aug; 88(16):8911-23. PubMed ID: 24872590
[TBL] [Abstract][Full Text] [Related]
11. TRIM5α and Species Tropism of HIV/SIV.
Nakayama EE; Shioda T
Front Microbiol; 2012; 3():13. PubMed ID: 22291694
[TBL] [Abstract][Full Text] [Related]
12. Retroviral restriction factors TRIM5α: therapeutic strategy to inhibit HIV-1 replication.
Zhang J; Ge W; Zhan P; De Clercq E; Liu X
Curr Med Chem; 2011; 18(17):2649-54. PubMed ID: 21568899
[TBL] [Abstract][Full Text] [Related]
13. Cytoplasmic body component TRIM5{alpha} requires lipid-enriched microdomains for efficient HIV-1 restriction.
Ohmine S; Sakuma R; Sakuma T; Thatava T; Solis GP; Ikeda Y
J Biol Chem; 2010 Nov; 285(45):34508-17. PubMed ID: 20810659
[TBL] [Abstract][Full Text] [Related]
14. The V86M mutation in HIV-1 capsid confers resistance to TRIM5α by abrogation of cyclophilin A-dependent restriction and enhancement of viral nuclear import.
Veillette M; Bichel K; Pawlica P; Freund SM; Plourde MB; Pham QT; Reyes-Moreno C; James LC; Berthoux L
Retrovirology; 2013 Feb; 10():25. PubMed ID: 23448277
[TBL] [Abstract][Full Text] [Related]
15. An Essential Role of INI1/hSNF5 Chromatin Remodeling Protein in HIV-1 Posttranscriptional Events and Gag/Gag-Pol Stability.
La Porte A; Cano J; Wu X; Mitra D; Kalpana GV
J Virol; 2016 Nov; 90(21):9889-9904. PubMed ID: 27558426
[TBL] [Abstract][Full Text] [Related]
16. Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle.
Yap MW; Dodding MP; Stoye JP
J Virol; 2006 Apr; 80(8):4061-7. PubMed ID: 16571822
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 with gag processing defects activates cGAS sensing.
Sumner RP; Blest H; Lin M; Maluquer de Motes C; Towers GJ
Retrovirology; 2024 May; 21(1):10. PubMed ID: 38778414
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 Mutant Assembly, Processing and Infectivity Expresses Pol Independent of Gag.
Yu FH; Huang KJ; Wang CT
Viruses; 2020 Jan; 12(1):. PubMed ID: 31906562
[TBL] [Abstract][Full Text] [Related]
19. Identification of residues within the L2 region of rhesus TRIM5alpha that are required for retroviral restriction and cytoplasmic body localization.
Sastri J; O'Connor C; Danielson CM; McRaven M; Perez P; Diaz-Griffero F; Campbell EM
Virology; 2010 Sep; 405(1):259-66. PubMed ID: 20633914
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
